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INTRODUCTION
1INTRODUCTION
Intractable epilepsies constitute a small but a significant proportion of all
epilepsies in childhood1. Intractable epilepsy is a major health problem in many
areas of the world. Chronic uncontrolled epilepsy can have serious medical
consequences including an increased risk of mood disorders, physical injuries and
sudden unexpected death. Intractable seizures are a major economic burden to the
society29.
            In majority of the children epilepsy remains a mild disorder with 60-80%
remitting spontaneously or with treatment25 .Seizure control remains poor in 10 -
20%17.  A  prompt  diagnosis  of  refractoriness  is  of  paramount  importance  for
consideration of other therapies such as surgery. Early surgical intervention when
successful might also prevent or reverse psychosocial consequences and cognitive
impairment of uncontrolled seizures during critical periods of development29.
REVIEW OF
LITERATURE
2REVIEW OF LITERATURE
           Epilepsy is a disorder of the brain characterized by enduring predisposition to
generate epileptic seizures16. The prognosis of epilepsy is generally good, but 10 -20
% have persistent seizures refractory to drugs and these cases pose a diagnostic and
management challenge17. These groups of patients are included as “treatment
nonresponders”, “refractory”, “intractable” and “drug resistant”. All these terms are
used interchangeably.
    The epidemiology of refractory epilepsy is complicated by several issues:
1. There is no unifying definition of refractory epilepsy.
2. Patients do not necessarily become refractory at the time of diagnosis, nor do
they remain refractory throughout the course of illness.
3. There is reasonable evidence from clinical trials that patients who are defined
as refractory will respond readily, although not completely to therapy22.
         Intractable epilepsy is poorly defined. Some authors apply the term to cases
that continue to be active despite “relevant therapy” but what constitutes relevant
therapy varies considerably both in terms of agents used and duration of trials21.
         Berg et al defined intractability as failure of seizure control with more than 2
first line AED with an average of 1 seizure per month for 18 months and no more
than a three months seizure free period during that interval26.
3         Camfield et al defined intractability as at least one seizure each 3 months for
the last year of follow-up with failure of at least 3 AED6.
        In an Indian study Chawla et al defined intractable epilepsy with “at least one
seizure per month over the last 6 months2.
       The ILAE commission gave a consensus proposal that ‘drug resistant epilepsy is
defined as failure of adequate trials of 2 tolerated, appropriately chosen and used
AED schedules whether as monotherapy or in combination to achieve sustained
seizure freedom23.
PREDICTIVE FACTORS OF INTRACTABLE EPILEPSY:
AGE OF ONSET OF SEIZURES:
 This is probably the most consistent factor in most studies3, 5. Seizure in an
immature brain of a child may result in nonpruning of neurons and contribute to
high number of gap junctions, which lead to abnormal connectivity, the
hyperconnected cortex leading to more epileptogenicity24.
TYPE OF SEIZURES:
 Tonic, myoclonic seizures are the types which are difficult to control25.
Atypical absence14, complex partial and even generalised tonic clonic seizures11
have been identified in some studies. Typical absence seizures on the other hand are
negatively correlated with intractability25.
4SEIZURE FREQUENCY:
High seizure frequency (>1/ month) occurring soon after the diagnosis of
epilepsy either before or after treatment also correlates with refractoriness26.
RESPONSE TO PREVIOUS AED:
      Within a given epileptic syndrome the probability of achieving a good
response to treatment is inversely proportional to the number of drugs to which the
patient has previously not responded27.  Absence  of  seizure  freedom  when  2  past
AED proved insuffient is a crucial predictor of refractoriness28.
EPILEPTIC SYNDROMES:
      West syndrome, Lennox Gastaut syndrome, Progressive myoclonic epilepsy
are the most common syndromes identified in this group14.
STRUCTURAL CEREBRAL ABNORMALITIES:
      The localization of the epileptogenic zone and type of structural cerebral
abnormalities also seem to play an important role in refractoriness. The temporal
lobe is the most common of focal epilepsy syndromes. The motor, sensorimotor
cortex are other areas with low seizure threshold29.
EEG:
 The EEG finding useful for predicting refractoriness includes multifocal and
frequent interictal spikes, interictal pattern like Hypsarrythmia and burst
suppression29.
5FEATURES OF MEDICAL INTRACTABILITY:
ETIOLOGIES:
      Perinatal Asphyxia, Neurocutaneus syndromes - Sturge Weber, Tuberous
Sclerosis, developmental malformations, sequelae of cerebral infection, infarction,
trauma, Mesial temporal sclerosis, cerebral tumors, idiopathic.
CATASTROPHIC EPILEPSIES:
      The catastrophic epilepsies include West syndrome, Lennox – Gastaut
syndrome, progressive myoclonic epilepsies.
COMMON CLINICAL FEATURES:
      The common clinical features associated with intractable seizures in children
include Mental retardation and focal neurological deficits 30.
EPILEPTIC SYNDROMES:
EARLY MYOCLONIC ENCEPHALOPATHY:
        It has its onset in the neonatal period. It is characterised by occurrence of
frequent, refractory generalised, focal or fragmentary myoclonia, focal clonic
seizures and epileptic spasms. There is a high frequency of familial cases. EEG
shows a pattern known as suppression – burst. It is highly resistant to treatment,
carries a high mortality and survivors are nearly all severely retarded32.
6OHTAHARA SYNDROME:
        It has its onset in the neonatal period. It is characterised by frequent tonic
spasms. The etiology is heterogeneous but structural brain abnormalities are
common. Seizures are highly resistant to treatment and there is an appreciable
mortality with survivors nearly always being severely retarded32.
WEST SYNDROME:
        It consists of a triad of Hypsarrythmia, epileptic spasms and psychomotor
retardation. Epileptic spasms involve contraction of the axial muscles causing
flexion, extension or both. Typical Hypsarrythmia is defined more or less continuous
abnormal EEG with high amplitude, irregular and asymmetrical slow wave activity
across all leads with random sharp waves and spikes producing chaotic pattern.
Tuberous Sclerosis is a common cause of infantile spasms. Other causes are brain
malformations, chromosomal abnormalities, and neurodegenerative diseases,
perinatal prenatal, postnatal destructive lesions, and brain tumors32.
LENNOX-GASTAUT SYNDROME:
       Children display a combination of frequent myoclonic and tonic seizures and
when interictal  slow waves are evident in EEG the seizure disorder is  classified as
Lennox-Gestaut syndrome. This syndrome is characterized by intractable seizures of
various types, slow spike wave EEG during the awake state and mental retardation17.
7RASMUSSEN SYNDROME:
        Rasmussen encephalitis is characterized by intractable focal motor seizures,
often evolving into epilepsia partia continua, cognitive decline and progressive
hemiparesis. Recent findings of glutamate receptors antibodies in some patients with
Rasmussen encephalitis implicate an autoimmune pathology33.
IMMATURE BRAIN AND PROPAGATION
THE HYPERCONNECTED CORTEX:
          Seizures of the immature brain may lead to failure of pruning or apoptosis,
imprinting abnormal connectivity termed as Hyperconnected cortex enhancing
epileptogenesis.
GAP JUNCTIONS:
          Neuronal gap junctions are abundant in the immature brain, which harbours
transient and extensive coupling between neurons. Epileptic activity in childhood
may preserve the quantity of gap junctions contributing to abnormal network or
Hyperconnected cortex enhancing epileptogenesis.
         The above mechanisms are two among the possibly many discovered or yet
undiscovered mechanism that not only enhance epileptogenecity but also confound
clinical and laboratory analysis of these patients31.
8SOME FACTORS AUGURING INTRACTABILITY
GENERALISED EPILEPSIES:
1. Onset in infancy or early childhood.
2. High initial seizure frequency.
3. Failure of initial appropriate AED
4. EEG showing multifocal bisynchronous spikes, abnormal background
activity.
FOCAL EPILEPSIES:
1. Region – temporal, occipital, primary motor cortex, supplementary sensory
motor area.
2. Etiology – Mesial temporal sclerosis, cortical dysplasias, hemorrhagic
lesions31.
9      EVALUATION AND MANAGEMENT OF INTRACTABLE EPILEPSY
Patients with intractable epilepsy should be referred to an epilepsy specialist
for diagnostic evaluation, to confirm refractoriness, optimization of
pharmacotherapy and consideration of other therapies such as epilepsy surgery.
The evaluation should be done to
? Establish a diagnosis of epilepsy-rule out pseudo refractory seizures
? Define Electroclinical syndrome- EEG (routine EEG is useful for clinical
diagnosis of epilepsy and elucidation of the underlying syndrome).
? Establish etiology of epilepsy
? Evaluate medical treatment- proper choice of AED and side effect profile
? Select ideal surgical candidates29.
  DIFFERENTIAL CONSIDERATIONS IN INTRACTABLE EPILEPSY
          ERRORS IN DIAGNOSIS:
? Failure to identify a seizure syndrome or causative condition
? Incorrect seizure classification (partial or generalised)
? Non-epileptic seizures (syncope, pseudoseizures)
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 ERRORS IN DRUG CHOICE OR MANAGEMENT:
? Wrong drug for the seizure type or seizure syndrome
? Inadequate dose of medication.
 POOR MEDICATION COMPLIANCE:
? Inadequate patient instructions or education
? Too frequent or complex dosing schedules
? Intolerable adverse effects of the medication.
 TRUE PHARMACOLOGICAL INTRACTABILITY30.
INVESTIGATIONS:
 EEG:
        The most commonly performed neurodiagnostic study in the evaluation of
patients with seizures is EEG. Routine EEG lasting for 20-30 minutes has a low
diagnostic yield. A more prolonged recording including sleep may be helpful in
identifying potentially epileptogenic activity that is not evident on awake-only
recording. The most reliable abnormalities on EEG are the primary generalised spike
and wave discharge and focal spike or sharp wave discharges on the frontal or
temporal lobes. These are highly epileptogenic findings and clinically greater than
85% of individuals with these findings experience clinically significant seizures30.
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VIDEO EEG:
         The limitations of standard EEG have led to the expanded use of prolonged
EEG recording with or without concurrent video recording. The combined use of
EEG and video recording improves the sensitivity and specificity of EEG alone.
Prolonged recording of EEG is an extremely helpful tool in evaluation of medically
intractable  seizures.  It  can  be  performed  in  an  inpatient  or  outpatient  basis.  Video
EEG monitoring has been demonstrated to accurately differentiate epileptic and
nonepileptic seizures, to distinguish between generalised and partial seizures, seizure
onset, localisation and lateralization30.
MRI SCAN:
             MRI scans have greatly enhanced the ability to visualize intraparenchymal
brain structures. This modality provides some of the sensitive and specific
neuroimaging data for localization of the epileptogenic zone. The newer techniques
in MRI are innovative. Use of thin contiguous cuts of 1.5 to 1.6 mm in multiple
sections has allowed detection of hippocampal atrophy as well as identification of
small areas of focal cortical dysplasia. Quantitative volumetric analysis has resulted
in determination of unilateral or bilateral hippocampal atrophy. FLAIR technique
(fluid attenuated inversion recovery imaging) highlights lesions such as mesial
temporal sclerosis and malformations of cortical development and identifies small
previously unidentifiable lesions. Diffusion tensor imaging is an MRI imaging
technique that helps in identifying white matter tracts that may be disrupted in
cortical dysplasia33.
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CT SCAN:
                CT scan may complement MRI scan in those with calcified lesions and
bony abnormalities30.CT  scan  is  still  used  in  special  etiologies  where  there  are
calcifications like tuberous sclerosis or cysticercosis which is difficult to detect on
MRI scan34.
FUNCTIONAL NEUROIMAGING:
                This includes single photon emission computed tomography (SPECT),
positron emission tomography (PET), functional MRI (fMRI) and Magnetic
Resonance spectroscopy (MRS). All these are aimed at identifying seizure onset
zone. MRS is useful in patients who have otherwise normal MRI29.
TREATMENT:
      Medical and surgical treatment options for epilepsy have improved in the
past decade. The risk of potential benefits of curative or palliative surgery must be
weighed against the chance of improvement and potential side effects of additional
medical therapy
OPTIMISATION OF PHARMACOTHERAPY:
          Using a systematic protocol in treatment of refractory epilepsy using new
AED might improve seizure control in a substantial proportion of cases29. The
nihilistic view that intractability is inevitable if seizure control is not obtained in a
few years of onset of therapy is incorrect35. Refractory epilepsy can be managed
systematically with AED until maximal dose is reached; if no response replace
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AED; if there is a partial response add another AED which should be differ from the
mechanism of action of the first AED36.
           Intractable generalised epilepsy is treated with lamotrigine with 60% children
showing some response. There seem to be synergism with valproate and up to 35%
become seizure free when both are used. Dose escalation should be very gradual
because there is a risk of Steven Johnson syndrome. Topiramate seems to be
effective though some evidence suggests better control of partial seizure than
generalised seizures37. Vigabatrin and gabapentin are best avoided because of the
tendency to exacerbate myoclonic seizures38, 39. Vigabatrin is useful in infantile
spasms due to Tuberous Sclerosis.
           Newer AED which are available like clobazam, vigabatrin, topiramate,
lamotrigine and gabapentin can be used for intractable partial seizures. Clobazam,
vigabatrin and topiramate are the most effective39, 40, 41,42.
ELEMENTS OF SUCESSFUL TREATMENT
? Classify the seizure disorder correctly
? Maximize monotherapy over polytherapy
? Balance the maximal effective dose with minimal side effects
? Choose dosing to maximize compliance
? Treat the patient's symptoms, not the EEG findings or the serum levels
The goal of treatment should be to achieve complete seizure control without side
effects30.
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SURGERY:
              Surgery for epilepsy is more complicated. It is often difficult to wait with
medical management as childhood epilepsies can be unpredictable at times with a
small but definite remission rate5.
               The common surgical procedures are
Temporal lobectomy:
        This procedure is performed in adolescents and adults. It involves temporal
lobectomy and amydalo-hippocampectomy because the removal of the mesial
temporal structures is associated with a good surgical outcome.
Cortical resection:
       Cortical resection is commonly performed in children, often involving extensive
lobar  or  multilobar  resection.  The  extent  of  resection  depends  on  the  extent  of  the
lesion.
Hemispherectomy:
        It is performed in young children. It is done for catastrophic epilepsies in which
the substrate of epilepsy is limited to one hemisphere. Epileptic syndromes which
meet these criteria include Sturge-Weber syndrome, hemimegalencephaly and
Rasmussen’s encephalitis.
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Multiple subpial transections:
             Multiple subpial transection is a newer surgical treatment which involves
disruption of the horizontal fibers when the epileptogenic zone overlies a functional
cortex.
Corpus callosotomy:
            It can reduce seizures in selected patients and is used in children with
Lennox-Gastaut syndrome33.
OTHER MODALITIES OF TREATMENT
Ketogenic diet:
            The Ketogenic diet is a high fat, adequate protein, low carbohydrate diet
used in treating refractory epilepsy in pediatric patients. As there is low
carbohydrate in the diet the liver convert’s fat into fatty acid and ketone bodies. The
ketones replace glucose as the energy source in the brain. An elevation of ketones in
the blood known as ketosis leads to reduction in frequency of epileptic seizures16.
Vagal nerve stimulation:
Electrical impulses are sent to the left vagal nerve in the neck via the lead
wire implanted under the skin. A 50% seizure reduction has been reported in one
third of the patients29.
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            Anne .T. Berg et al performed a case control study to identify the early
predictors of medically intractable epilepsy in children. Cases were children who
had an average one seizure or more a month over a 2 year period and who during
that time had failed trials of three different drugs. Controls were children who had
epilepsy who has been seizure free for two years and who never before becoming
seizure free met the definition of intractable epilepsy. Strong univariate association
was noted between intractability and infantile spasms, remote symptomatic epilepsy,
history of status epilepticus, neonatal seizures, microcephaly. Cases were
significantly younger than controls. With multiple logistic regressions independent
predictors of intractability were infantile seizures, age at onset with a decreasing risk
with increasing age, remote symptomatic epilepsy3.
Manoj Gulabrao et al conducted a prospective case control study on the
clinical profile, aetiopathogenesis, outcome and clinical predictors of intractable
epilepsy. 38 children met criteria of intractable epilepsy while remaining 55 had well
controlled epilepsy. All patients were analysed by taking a detailed history of
prenatal events, seizure semiology and detailed antiepileptic therapy. Demographic
profile revealed that 90% of children were above 4 years, there was a significant
male preponderance in both age groups. 60% subjects had onset less than 1year.
Remote symptomatic aetiology was the main aetiology (71%).Univariate analysis
showed that factors that predict intractabilility were early onset seizures, myoclonic,
neonatal or mixed seizures, initial high seizure frequency, perinatal asphyxia,
neurological impairment, microcephaly, neuroimaging, EEG abnormalities.
Multivariate analysis revealed early onset of seizures, mixed seizures, neurological
impairment microcephaly had independent intractability1.
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           Chawla et al performed a case control study comprising 50 cases and 50
controls to determine the etiology and clinical predictors of epilepsy. Patients
included children who had one seizure per month over the last 6 months. Controls
include children with epilepsy who had been seizure free for more than 6 months.
A detailed history and clinical examination was done. Epilepsy in study group was
caused by perinatal problems (48%), sequelae of CNS infection (24%) and
idiopathic (20%). In the control groups epilepsy was idiopathic (72%), calcified
granuloma 22% and perinatal problems 6%.On univariate analysis strong association
was evident between intractable epilepsy and several factors including age of onset
of seizures, remote symptomatic epilepsy, initial seizure type, history of neonatal
seizures, high initial seizure frequency, microcephaly and neurological impairment.
On multivariate analysis neurological impairment, age of onset <1 year, myoclonic
seizures / infantile spasms, remote symptomatic epilepsy were independent
Predictors of IE2.
           Javad Akhondian et al performed a study in children less than 15 years at
Paediatric Neurology clinic of Imam Reza Hospital. There were two groups. Group
1 consisted of 51 patients with refractory seizures.  Group 2 consisted of 80 well
controlled patients who were seizure free for past 6 months. Age of onset <1 year,
multiple seizures before starting treatment, male gender, myoclonic seizures,
neurological defects, neonatal seizures, daily seizures and first abnormal EEG & CT
Scan are the factors affecting occurrences of refractory seizures4.
         Huttenlocher et al performed a study with145 children who had refractory
seizures for two years and they were followed for 5 to 20 years after onset .Majority
of them (61%) were mentally retarded and many of them had age of onset less than
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2 years of age (73%). Age of onset was a little later in the group with borderline to
normal intelligence.
Follow up showed remission of seizures in children with borderline to
normal intelligence, with a linear decrease of percentage with persistent seizures at
the rate of 4% per year. Remission of seizures was much less in the group with
mental retardation (1.5%).  Seizure type had some effect on outcome. Children with
focal atrophic brain lesion did not worse more than those without definable
pathology of brain imaging studies5.
          Camfield et al performed a population based study to find which child
epilepsy will remit. EEG allowed identification of all children from Nova Scotia
1977-1985. Children were followed over an average of 7 years. On the basis of
clinical characteristics multivariate analysis was used to develop a scoring scheme to
predict  remission.  At  diagnosis  the  best  predictors  of  remission  were  age  of  onset
less than 12 years, normal intelligence, no prior neonatal seizures, they concluded
that 55% of childhood epilepsy will remit6.
Atlunbasak et al studied the prognosis of the patients with seizure onset from
1-24 months of age. They also studied predictive factors regarding unfavourable
prognosis.75 patients were retrospectively analyzed. Mental retardation,
neurological abnormality, infantile spasm, use of > 1 antiepileptic drug, epileptic
activity on EEG, status epilepticus, symptomatic etiology, seizure frequency > 1 per
week, H/o perinatal anoxia and neonatal seizures were significant risk factors
regarding epilepsy prognosis. On multivariate analysis perinatal anoxia, infantile
spasms, status epilepticus were significant for epilepsy prognosis. Status epilepticus
and anoxia are unfavourable predictive risk factors regarding prognosis of patients
with seizures that have an onset between 1 – 24 months of age7.
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         Singhvi et al performed a study to find out the profile of intractable epilepsy
.100 patients among whom 67 males, 33 females, attending epilepsy clinic were
evaluated. Detailed history, examination, EEG, CT and details regarding
pharmacotherapy were analysed. The age of the patients ranged from 5-70 years.
Commonest seizure type was partial seizures. 50 patients had one or more abnormal
predictors. 57 patients were in the symptomatic group with CNS infection being the
major cause. EEG was abnormal in 69% of the cases, CT abnormal 41% cases. The
presence or absence other predictors does not predict the severity of the epilepsy.
Addition of third drug only increased adverse effects8.
Malik et al studied 325 (74%) children with intractable epilepsy who had
seizures even after 2 years of adequate treatment. They were compared with 117
(26%) controls who did not have seizures for >1 year. Adequate treatment was
described > 3 AED’s with proper compliance and dosage. Male gender, seizure
frequency in infancy, myoclonic seizures, neonatal seizures, abnormal EEG,
cryptogenic epilepsy and head trauma were factors associated with intractable
epilepsy9.
           Aithala et al performed a cases control study in the United Arab Emirates
with 55 children with intractable epilepsy and 50 children as controls. Age of onset
<1 year, high seizure frequency at onset, positive history of neonatal seizures,
developmental delay, status epilepticus, neurological deficits and abnormal
neuroimaging  were found to be more significantly associated with the cases.
Symptomatic localization related epilepsy was more common in children in the
cases10.
AIMS & OBJECTIVES
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                                AIMS AND OBJECTIVES
          (1)   To study the clinical profile of intractable seizures.
                   (2)  To determine the clinical predictors of intractable seizures.
STUDY JUSTIFICATION
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                            STUDY JUSTIFICATION
Identification of predictors of intractable epilepsy is important to identify
cases early in the course of the disease. The clinical characteristics of intractable
seizures are poorly understood and current managements are unsatisfactory.
However there are very few studies on intractable seizures. Identification of
predictors early in the course of the disease can help in selecting appropriate
antiepileptic drugs and select children who are appropriate candidates for surgery.
            A long term follow up of children with intractable seizures was done by Berg
et al26 and his colleagues3. As there is no unifying definition for intractable seizures,
we have used Berg et al26 definition for identification of the cases. Intractability for
an individual child is difficult to predict before several years of antiepileptic drug
treatment. Intractability appears to decrease with prolonged follow-up, although the
burden of this wait and see approach is substantial. Failure of a first antiepileptic
drug is a risk factor for intractability but nonetheless many remit33.
STUDY MATERIALS &
METHOD
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MATERIALS AND METHODS
STUDY DESIGN:
          Prospective case control study
PERIOD OF STUDY:
           Jan 2010 - Aug 2011
PLACE OF STUDY:
Institute Of Social Pediatrics
Stanley Medical College
STUDY POPULATION:
Children with seizures aged 1-12 years
INCLUSION CRITERIA:
Children aged 1 -12 years who met the definition of intractable seizures
Both sexes
EXCLUSION CRITERIA:
Children with poor compliance to AED
Parents not willing to participate
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CASE DEFINITION:
       Intractable epilepsy is when seizures continue to occur despite maximally
tolerated doses of more than two antiepileptics, occurrence of an average of one
seizure  per  month  for  18  months  with  no  more  than  a  3  month  seizure  free  period
during these 18 months.
CONTROLS DEFINITION:
       Epileptic children who had good control of seizures for the past 1½ Yrs
STUDY DETAILS:
             All  children  attending  Institute  Of  Social  Pediatrics  with  seizures  were
studied. 63 children met the criteria of intractable epilepsy and were included in the
case group. Controls were selected by random sampling of children who had good
control of seizures for the past 1½ years. Our study had a total of 126 children,
63 cases and 63 controls. The children were enrolled into the study after getting
consent from the parents. The study was conducted after Institutional Ethical
Committee approval was obtained
         A detailed history was obtained from the parents. History regarding seizure
semiology, no of AED, frequency of seizures was obtained. Details regarding age,
sex, age of onset of seizures, family h/o seizures, H/o febrile seizures, H/o of status
epilepticus, birth asphyxia, developmental delay, H/o neonatal seizures, were sought
from a detailed medical history. Clinical examination was performed for all the
cases. Parents were asked to maintain a diary to record the details of daily intake of
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drugs and to record details regarding occurrence of seizures. Compliance to AED’s
was assessed by a detailed history and a review of past medical records. The patients
were  asked  to  maintain  a  diary  after  enrollment  into  the  study  and  mark  the  daily
intake of drugs and the no of times the drug was taken.
         The diaries were reviewed every 2 weeks when the patients came to collect
medications. Only those children with good compliance were enrolled in our study.
Seizures were classified according to the ILAE classification of epileptic seizures.
           Urine for metabolic screening, LFT, RFT and EEG was done for all
children. CT scan brain was done for all children. MRI brain was done only for
selected cases.
           Patients underwent Ophthalmological and ENT evaluation. Pediatric
neurologist opinion was sought for all the children.
Data was collected and a computerised analysis of data was performed using
SPSS software packages. Data were analysed separately for univariate comparison.
Analysis  was  done  using  Chi  square  test.  A  P  value  of  <0.05  was  taken  to  be
significant. The Odds ratio was used to indicate the magnitude of association
between each parameter and intractable epilepsy.
RESULTS &
OBSERVATION
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RESULTS AND OBSERVATIONS
  A total of 598 children with seizure disorder attended our hospital during the
study period of one and half years among whom 63 children met the criteria of
intractability. In our study the prevalence of intractable seizures was 10.53%. A total
of 63 children in the intractable seizure group and 63 children in the well controlled
group were studied.
  AGE DISTRIBUTION OF THE STUDY POPULATION
TABLE -1
AGE IN YEARS CASES (63)
No.      %
CONTROLS (63)
No.        %
TOTAL (126)
No.          %
1-2 9     (14.3) 5         (7.9) 14        (11.1)
2-5 20    (31.7) 33       (52.4) 53        (42.1)
5-12 34     (54) 25      (39.7) 59        (46.8)
             Among the 126 children studied, maximum number of children 59 (46.8%)
belonged to the 5-12 years group with, 34 (54%) in the intractable group and
25(39.7%) in the well controlled  group.14 (11.1%) children belonged to the age
group 1-2 years with 9 (14.3%) children in the intractable group and 5 (7.9%)
children in the well controlled group. 53 (42.1%) children were in the 2-5 years
group with 20 (31.7%) in the intractable group and 33(52.4) children in the control
group.
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                         SEX DISTRIBUTION OF THE STUDY POPULATION
                                                              TABLE - 2
SEX
CASES
No.        %
CONTROLS
No.        %
MALES 45      (71.4) 40      (63.5)
  FEMALES 18       (28.6) 23       (36.5)
TOTAL 63      (100) 63      (100)
           The total no. of males in the study were 85 with 45 (71.4%) in the case group
and 40 (63.5%) in the control group. There was predominant male preponderance in
our study. There were 18 (28.6%) females among the cases and 23 (36.5%) females
among the controls.
                                                                MALE SEX
                                                                  TABLE - 3
SEX
CASES
No.        %
CONTROLS
No.        %
ODDS
RATIO
CONFIDENCE
INTERVAL
P VALUE
MALES 45      (71.4) 40      (63.5)       1.438  0.679 – 3.042      0.342
TOTAL 63      (100) 63      (100)
         Male sex was not significantly associated with intractable seizures in our study
with a P value of 0.342. The Odds ratio for male sex was not significant 1.438 with
95% confidence interval of 0.679 - 3.042.
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SEIZURE FREQUENCY OF THE STUDY GROUP
TABLE - 4
Initial seizure
frequency
CASES(63)
No.           %
CONTROLS(63)
No.            %
Daily 32         (50.8) -
>1/week 12          (19) -
>1/month 19         (30.2) -
>1/6 months - 19           (30.20)
>1/year - 44            (69.8)
         Children in the intractable seizure group had a higher seizure frequency
when compared to the control group.
           32 (50.8%) children had daily seizures, 12 (19%) had more than 1
seizure/week and 19 (30.2%) children had more than 1seizure/month in the
intractable group.
          19 (30.20%) children had more than 1 seizure/6 months and 44 (69.8%)
children had more than 1 seizure/ year in the well controlled group.
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TYPE OF SEIZURES
TABLE - 5
TYPE OF
SEIZURE
CASES
No.          %
CONTROLS
No.         %
ODDS
RATIO
CONFIDENCE
INTERVAL
P
VALUE
GENERALISED   48     (76.2) 45        (71.4)      1.280 0.577 – 2.840     0.543
PARTIAL 15       (23.8) 18        (28.6)      0.781 0.352- 1.733     0.543
TOTAL 63         (100) 63        (100)
       The commonest seizure in our study was generalized seizures with 48
(76.2%) children in the intractable group and 45 children (71.4%) in the control
group. Generalised seizure was not significant in the cases with a P value of 0.543
and an Odds ratio of 1.280 with a 95% confidence interval of 0.577 – 2.840.
       Partial seizures were seen in 15 (23.8%) children in the intractable group and
18 (28.6%) children in the well controlled group. Partial seizures were not
significantly associated with intractable seizures with a P value of 0.543 and odds
ratio of 0.781 with a 95% confidence interval of0.352-1.733.
      2 children among the cases had more than one type of seizure with mental
retardation and slow wave activity on EEG and had features of Lennox-Gastaut
syndrome.
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TYPE OF SEIZURES
TABLE - 6
            TYPE OF SEIZURES
          CASES
     No.           %
     CONTROLS
      No.        %
          GENERALISED SEIZURES      48           (76.2)       45         (71.4)
  1          GTCS      18 (28.5)       30 (47.6)
  2         Tonic        7 (11.1)       10 (15.8)
  3         Clonic        3 (4.7)         3 (4.7)
  4      Myoclonic      20 (31.7)         2 (3.17)
         PARTIAL SEIZURES      15         (23.8) 18           (28.6)
 1     Simple partial        3 (4.7)       10 (15.8)
2    Complex partial        9 (14.3)        5 (7.9)
 3 Partial seiz. with sec.
generalization
       3 (4.7)        3 (4.7)
                 TOTAL      63 (100)      63 (100)
 Among children who had generalized seizures the commonest seizure type
was myoclonic seizures in the intractable group.20 children had myoclonic seizures
in the intractable group and 2 children in the control group. GTCS was the
commonest seizure observed in the control group with 30 children in the control
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group and 18 children in the intractable group.  The commonest type of partial
seizures was complex partial seizures with 9 children in the intractable and 5
children in the control group.
MYOCLONIC SEIZURES
TABLE - 7
TYPE OF
SEIZURES
   CASES(63)
  No.      %
CONTROLS
No.          %
ODDS
RATIO
CONFIDENCE
INTERVAL
   P VALUE
Myoclonic   20    (31.7)     2    (3.17)
14.18 3.149 - 63.89 < 0.001
   TOTAL   63    (100)   63    (100)
        Myoclonic seizures was significantly associated with intractable seizures in
the cases with a p value of <0.001 and odds ratio of 14.186 with a confidence
interval of 3.149 - 63.899.
No. OF AED TAKEN BY THE STUDY GROUP
TABLE – 8
No. of AED
CASES
No.        %
CONTROLS
No.          %
5 4         ( 6.3) -
4 7        (11.1) -
3 52       (82.5) 3          (4.8)
2 - 20         (31.7)
1 - 40         (63.5)
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       Maximum number of children in the cases were on 3 AED whereas
maximum number of children in the controls were on 1 AED. All the children in the
case  group were  treated  with  3  or  more  AED.  None  of  the  children  in  the  control
group were on more than 3 AED.
AGE OF ONSET OF SEIZURES <1YR
TABLE- 9
AGE OF
ONSET
    CASES
  No.         %
CONTROLS
   No.       %
    ODDS
RATIO
CONFIDENCE
INTERVAL
P VALUE
     <1 yr 39      (61.9) 14    (22.2)      5.688 2.602 - 12.431     <0.001
TOTAL 63     (100) 63    (100)
     39 (61.9%) children in the cases and 14 (22.2%) children among the controls
had age of onset <1 yr.  24 (38.1%) children among the cases and 49 (77.8%)
children among the control had age of onset of seizures >1 year.
         The age of onset < 1yr in the cases was significant with P value of <0.001
and Odds ratio of 5.688 with a 95% Confidence interval of 2.602 -12.431.
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FAMILY H/O SEIZURES, H/O FEBRILE SEIZURES AND CNS
INFECTIONS
TABLE - 10
Parameter CASES(63)
No.      %
CONTROLS (63)
No.                  %
ODDS
RATIO
CONFIDENCE
INTERVAL
P VALUE
Family H/O
Seizures 8     (12.7) 15             (23.8) 0.465 0.182 – 1.193 0.106
H/O Febrile
Seizures 20    (31.7) 16              (25.4) 1.366 0.628 – 2.971 0.430
CNS
Infections 2      (3.2) - - - 0.154
         Family  H/o  seizures  was  not  significant  among the  cases  with  a  P  value  of
0.106 and odds ratio of 0.465 with a 95% confidence interval of 0.182 – 1.193.
             20 children among the cases had H/o febrile seizure with an insignificant
p value-0.430 and odds ratio of 1.366 with a 95% confidence interval of 0.628 –
2.971.
            2  children  in  the  cases  had  H/o  fever  with  altered  sensorium  and
cerebrospinal fluid analysis suggestive of Central nervous system infection with an
insignificant p value 0.154.
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STATUS EPILEPTICUS AND NEONATAL SEIZURES
TABLE – 11
Parameter CASES (63)
No.           %
CONTROLS (63)
No.           %
ODDS
RATIO
CONFIDENCE
INTERVAL
P VALUE
H/o status
epilepticus 32       (50.8)     12            (19)   4.387  1.972 – 9.760    < 0.001
H/o
neonatal
seizures
13       (20.6)      5           (7.9)   3.016  1.005 – 9.048      0.042
            32 (50.8%) children among the cases and 12 (19%) children among the
controls had a history status epilepticus. 31 (49.2%) children among the cases and 51
(81%) children among the controls did not have history of status epilepticus.
Children with intractable seizures had a higher incidence of status epilepticus with a
significant P value of <0.001 and an Odds ratio of 4.387 with a 95% confidence
interval of 1.972 – 9.760.
             13 (20.6%) children among the cases and 5 (7.9%) children among the
controls had H/o neonatal seizures in the past. 50 (79.4%) children among the cases
and 58 (92.1%) children among the controls did not have a history of neonatal
seizures. H/o neonatal seizure was a risk factor for intractable seizures with a
significant P value- 0.042 and an Odds ratio of 3.016 with a 95% confidence interval
of 1.005 - 9.048.
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 BIRTH ASPHYXIA AND DEVELOPMENTAL DELAY
TABLE - 12
PARAMETER CASES(63)
No.         %
CONTROLS(63)
No.         %
ODDS
RATIO
CONFIDENCE
INTERVAL
P
VALUE
  H/o birth
asphyxia
29        (46) 9      (14.3) 5.118 2.161 -12.121 < 0.001
H/o
developmental
delay
34        (54) 6      (9.5) 11.138 4.196 – 29.566 <0.001
               29 (46%) children among the cases and 9 (14.3%) children among the
controls had a history suggestive of birth asphyxia. 34 (54%) children among the
cases and 54 (85.7%) children among the controls did not have a history of birth
asphyxia. H/o birth asphyxia in the cases was significant with a P value of <0.001
and an Odds ratio of 5.118 with a 95% confidence interval of 2.161 - 12.121.
               34 (54%) children among the cases and 6 (9.5%) children among the
controls had a history of developmental delay. 29 (46%) children among the cases
and 57 (90.5%) children among the controls were developmentally normal. H/o
developmental delay is significant in the cases with a P value of <0.001 and an Odds
ratio of 11.138 with a 95% Confidence interval of 4.196 – 29.566.
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ABNORMAL NEUROLOGICAL EXAMINATION
TABLE - 13
PARAMETER CASES
No.        %
CONTROLS
No.         %
ODDS
RATIO
CONFIDENCE
INTERVAL
P VALUE
Abnormal
neurological
examination
41      (65.1) 9       (14.3)
11.182 4.660 – 26.834 <0.001
TOTAL
63      (100) 63       (100)
       Among the cases 41 (65.1%) children had an abnormal neurological
examination when compared to only 9 (14.3%) children in the control group.
22(34.9%) children among the cases and 54 (85.7%) among the controls were
neurologically normal.
            Abnormal neurological examination seen in the cases was statistically
significant with a P value of <0.001 and an Odds ratio of 11.182 with a 95%
confidence interval of 4.660 – 26.834.
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FINDINGS ON NEUROLOGICAL EXAMINATION
TABLE – 14
Neurological
Examination
CASES(63)
  No        %
CONTROLS(63)
  No             %
ODDS
RATIO
CONFIDENCE
INTERVAL
  P
VALUE
Neurocutaneous
markers 4        (6.3) 3           (4.8) 1.356 0.291 - 6.322 0.697
   Microcephaly 25      (39.7) 4           (6.3) 9.704 3.130 - 30.084 < 0.001
Vision
Abnormalities 4      (6.34) 2          (3.17) 1.356 0.748  - 2.457 0.403
Language
Delay 19     (30.15) 2          (3.17) 2.159 1.657 - 2.813 < 0.001
Hemiplegia 3        (4.7) 1          (1.58) 1.525 0.842 – 2.762 0.310
Quadriplegia 15       (23.8) 2          (3.17) 2.004 1.524 – 2.634 < 0.001
          25 (39.7%) children had microcephaly among the cases which was significant
with a P value of <0.001 and Odds ratio of 9.704 with a confidence interval of
3.130- 30.084.
 19 (30.1%) children had language delay among the cases which was
significant with a P value of <0.001and odds ratio of 2.159 with confidence interval
of 1.657-2.813
15 (23.8%) children had quadriplegia among the cases with significant P
value of <0.001 and Odds ratio of 2.004 with 95% confidence interval of 1.524-
2.634.
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 4 children in the cases had neurocutaneus markers suggestive of Tuberous
sclerosis. Other findings were vision abnormalities 4 (6.32%) and hemiplegia 3
(4.7%) among the cases.
      2 children among the controls had features suggestive of neurofibromatosis
and one child had tuberous sclerosis.
ABNORMAL EEG
TABLE- 15
PARAMETER CASES
No.       %
CONTROLS
No.        %
ODDS
RATIO
CONFIDENCE
INTERVAL
P VALUE
Abnormal EEG 53      (84.1) 30      (47.6)
5.830 2.524 – 13.468 <0.001
TOTAL 63      (100) 63       (100)
 EEG was abnormal in 53 (84.1%) cases when compared to 30 (47.6%)
children in the controls. 10 (15.9%) children among the cases and 33 (52.4%)
children among the controls had a normal EEG. The abnormality noted in most of
the children was bilateral sharp wave discharges and multifocal sharp waves.
          Abnormal  EEG in  the  intractable  group was  significant  in  the  cases  with  a
P value of <0.001 and Odds ratio of 5.830 with a 95% Confidence interval of
2.524 -13.468.
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ABNORMAL CT SCAN BRAIN
TABLE- 16
  CT Scan CASES
No.        %
CONTROLS
No.          %
ODDS
RATIO
CONFIDENCE
INTERVAL
P VALUE
ABNORMAL  28     (44.4) 21      (33.3)       1.600  0.777 – 3.294       0.201
TOTAL  63     (100) 63        (100)
           CT  scan  was  done  in  all  the  children  enrolled  in  the  study.  CT  scan  was
abnormal in 28 (44.4%) cases and 21 (33.3%) controls. 35 (55.6%) children among
the cases and 42(66.7%) children among the controls had a normal CT scan.
       Abnormal CT scan in the cases was not significant with a p value of  0.201
and Odds ratio 1.600 with 95% Confidence interval of 0.777 – 3.294.
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FINDINGS ON CT SCAN BRAIN
TABLE – 17
FINDINGS ON CT
SCAN
CASES(63)
No.                       %
CONTROLS(63)
No.                     %
Normal      35                       (55.6)       42                      (66.7)
Cerebral atrophy        9                       (14.3)         1                      (1.58)
Gliosis       9                        (14.3)         3                      (4.76)
Cerebral atrophy + gliosis       2                        (3.17)         1                      (1.58 )
Tubers and calcification       4                       (6.34)         1                      (1.58)
Corpus callosum agenesis       2                       (3.17)                        -
Hydrocephalous       2                        (3.17)                        -
Ring enhancing lesion                      - 11                      (17.4)
Calcifications                      -         4                      (6.34)
35 (55.6%) children among the cases and 42 (66.7%) children among the
controls had a normal CT scan. 28 (44.4%) children among the cases and 21 (33.3%)
had abnormal findings on CT scan.
Among the cases the commonest neurological finding was cerebral atrophy
and gliosis.  9 (14.3%) children had cerebral atrophy and 9 (14.3%) children had
gliosis  among  the  cases.  2  (3.17%)  had  cerebral  atrophy  along  with  gliosis  in  the
intractable group. 4(6.34%) cases had tubers and calcification on CT scan. 2(3.17%)
children had agenesis of corpus callosum, 2 (3.17%) children had features of
hydrocephalous. The commonest finding in the control group was ring enhancing
lesion (17.4%).
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ABNORMAL MRI BRAIN SCAN
TABLE - 18
        MRI CASES
No.        %
CONTROLS
No.        %
P VALUE
ABNORMAL   35    (55.6)   12    (19.04)
0.005
NORMAL   19    (30.1)   30     (47.6)
NOT TAKEN    9     (14.3)   21     (33.3)
TOTAL   63     (100)   63      (100)
         MRI  was  not  done  in  9  cases  and  21  controls.  MRI  was  abnormal  in  35
(55.6%) children of the cases and 12 (19.04%) children of the controls. Abnormal
MRI was significant in the cases with a P value of 0.005.
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FINDINGS ON MRI BRAIN SCAN
TABLE-19
  FINDINGS ON MRI
SCAN
CASES
      No.                       %
CONTROLS
         No.                     %
 Normal     19                        (30.1)         30                     (47.6)
Cerebral atrophy     11                      (20.37)           2                     (4.76)
Gliosis      9                         (16.7)           3                     (7.14)
Cerebral atrophy + gliosis      3                         (5.5)           1                     (2.38)
Tubers      4                         (7.40)                     -
Neuronal migration defects      3                         (5.5)                      -
Hippocampal atrophy      2                         (3.70)                      -
Corpus callosum agenesis      2                         (3.70)                      -
Hydrocephalous      1                         (1.85)                      -
Ring enhancing lesion                    -           6                     (14.3)
MRI Scan was not taken in 9 cases and 21controls who had a lesion on
CT scan.
The commonest finding on MRI was cerebral atrophy which was seen in11
(20.37%) children. 9 (11.1%) children had features of gliosis and 3 (5.5%) children
had features of cerebral atrophy and gliosis. 4 (7.40%) children in the cases had
features of tuberous sclerosis. 2 (3.70%) children each in the cases had features of
hippocampal atrophy and agenesis of the corpus callosum. 3 (5.5%) among the cases
had features suggestive of neuronal migration disorders. There were 2 cases of
Polymicrogyria and one case of Lissencephaly. 1 (1.85%) child among the cases had
features of hydrocephalous.
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ETIOLOGY OF INTRACTABLE EPILEPSY
TABLE- 20
ETIOLOGY CASES
No.       %
CONTROLS
No.        %
REMOTE
SYMPTOMATIC
44    (69.8) 33      (52.3)
IDIOPATHIC 19    (30.15) 30     (47.61)
TOTAL 63     (100) 63     (100)
 In 19 (30.15%) children among the cases the etiology was idiopathic and 44
(69.8%) children had remote symptomatic etiology.
REMOTE SYMPTOMATIC ETIOLOGY
TABLE -21
ETIOLOGY CASES
No.        %
CONTROLS
No.          %
ODDS
RATIO
CONFIDENCE
INTERVAL
P VALUE
REMOTE
SYMPTOMATIC
44   (69.8) 33      (52.3)
2.1052
 1.013 – 4.371      0.044
TOTAL 63    (100) 63       (100)
         Remote symptomatic etiology was significantly associated with intractability
with a P value of 0.044 and Odds ratio of 2.1053 with a 95% confidence interval of
1.013 -4.371.
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ETIOLOGY OF INTRACTABLE SEIZURES AMONG THE CASES
TABLE- 21
ETIOLOGY     CASES
  No.         % ODDS
RATIO
CONFIDENCE
INTERVAL
P VALUE
Perinatal Asphyxia 29      (46)    5.118  2.161 -12.121     <0.001
Tuberous Sclerosis  4    (6.34)       1.641 1.021 - 2.638       0.170
Neuronal migration
disorders
 3    (4.76)         -         -       0.080
Corpus callosum agenesis  2    (3.17)        -         -       0.154
Hippocampal atrophy  2    (3.17)        -         -       0.154
Postmeningitic sequelae  2    (3.17)       -         -       0.154
Lennox-Gastaut syndrome  2    (3.17)       -         -       0.154
        The commonest cause of intractable seizures was perinatal asphyxia
29 (46%) followed by tuberous sclerosis 4 (6.34%). Other causes of intractability are
neuronal migration disorders 3 (4.76%), corpus callosum agenesis 2 (3.17),
hippocampal atrophy 2 (3.17%), Postmeningitic sequelae 2 (3.17%), Lennox-
Gestaut syndrome 2 (3.17%) cases. Perinatal asphyxia was significantly associated
with intractable seizures with a significant P value <0.001 and Odds ratio of 5.118.
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DISCUSSION
          The prevalence of intractable seizures was 10.53% in our study. Camfield
et al6 showed the prevalence of intractable seizures to be 8% in his studies. Sillanpaa
in his study showed the prevalence of intractable seizures to be 22%. Medically
intractable seizures is estimated to develop in 10- 20% of children with epilepsy12.
             In our study 67.5% of the children were males. There was a significant male
preponderance in both the groups. Similar results were seen by Javad Abhondian et
al4 (76.5%). Mallik et al9 also showed a male preponderance in his study. However
male sex was not significantly associated with intractable seizures in our study.
         In our study the incidence of daily seizures was 50.8% in the case group.
A  similar  result  was  shown  by  Manoj  et  al1 in his case group (50%). Javad et al4
showed the incidence of daily seizures to be 66.7% in his cases. The occurrence of
weekly  seizures  in  our  study  was  19%  and  these  matched  well  with  Manoj  et  al1
studies (20%). 30.2% of our cases had monthly seizures and our results matched
well with Manoj et al1 who showed the occurrence of monthly seizures to be 30%.
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TYPE OF SEIZURES
TABLE-23
COMMONEST SEIZURE TYPE
Present Study Generalized seizures
Chawla et al2 Generalized seizures
Ohtsuka et al13 Generalized seizures
Berg et al3 Generalized seizures
Singhvi et al8 Partial seizures
      The commonest seizure type in our study was generalized seizures. These
results  were  also  shown  by  Chawla  et  al2,  Ohtsuka  et  al13 and  Berg  et  al3 in their
studies.
          Among  the  seizure  types  Myoclonic  seizures  proved  to  be  an  important
predictor of intractability in our study. A similar result was shown by Chawla et al2,
Malik et al9 and Javad et al4 in their studies. Eriksson et al14, Udani et al11 and Berg
et al3 stated that myoclonic seizures/infantile spasms have the poorest seizure
control.
      82.5% of the cases were on 3 AED’s, 11.1% on 4 AED’s and 6.3% on
5 AED. 4.8% of the controls were on 3 AED’s. None of the children in the control
group was on more than 3 AED.
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AGE OF ONSET OF SEIZURES
TABLE -24
STUDIES AGE OF ONSET < 1 YEAR
Present Study 61.9%
Manoj  et al1 60%
Chawla et al2 66%
Ohtsuka et al13 53%
 In our study 61.9% of the children with intractable seizures had age of onset
< 1 year. This compared well with studies of Manoj et al1 (60%) and Chawla et al2
66%. However Ohtsuka et al13 in his study stated age of onset of seizures <1 year to
be 53%. In our study age of onset of seizures was a predictor of intractable epilepsy.
The reasons for early onset of seizures are due to the etiologies like perinatal
asphyxia, Tuberous sclerosis.
     12.7% of our cases had a family history of seizures. Family H/o seizure was
not significantly associated with intractable epilepsy in our study. These results go
along with Manoj et al1 and Javad et al4.
       Febrile seizure is a known risk factor for epilepsy the probable risk factor
being hippocampal damage due to hyperthermia (Bourgeois et al15). H/o febrile
seizure was not significantly associated with intractable seizures in our study. These
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results were comparable with Manoj et al1. H/o fever with altered sensorium was not
significantly associated with intractable seizures in our study.
          50.8% children presented with status epilepticus in the cases and when
compared to 19% of the children in the controls. Similar results were stated by
Manoj et al1 (55%). However Javad et al4 showed only 11.8% of the cases to have
status epilepticus. H/o status epilepticus was significantly associated with intractable
epilepsy  in  our  study.  These  results  went  well  with  Berg  et  al3 and  Manoj  et  al1.
However in Javad et al4 study  there  was  no  significant  association  between  status
epilepticus and intractable seizures. The explanation would be cause of an insult to
the growing brain.
        There were 46% of children with H/o perinatal asphyxia among the cases.
Chawla et al2 showed 50% of his cases with perinatal problems. Perinatal asphyxia
was a predictor of intractable epilepsy. Similar results were shown by Atlunbasak et
al7 and Manoj et al1.
        H/o developmental delay was significantly associated with intractable
epilepsy in our study. Similar results were shown by Aithala et al10 in his study.
Microcephaly among the cases (39.7%) was significantly associated with
intractable seizures in our study. Berg et al3,  Chawla  et  al2 and  Manoj  et  al1 also
showed similar results.
       Abnormal neurological examination was a predictor of intractable epilepsy in
our  study.  Chawla  et  al2, Javad et al4 and Atlunbasak et al7 also  showed  similar
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results. 40% of the children had microcephaly, 30 % children had language delay
and 25% had quadriplegia.
        Abnormal EEG among the cases was significantly associated with intractable
seizures in our study. Atlunbasak et al7 and  Singhvi  et  al8 (69%)  also  showed  the
same results in their study.
      Abnormal CT scan was seen in 44.4% of our cases.  Singhvi et  al8 reported
41% of abnormal CT scan among his cases. Abnormal CT scan among the cases was
not significantly associated with intractable epilepsy in our study. However Javad et
al4 and Singhvi et al showed association between abnormal CT and intractable
epilepsy.
       Abnormal  MRI  scan  among  the  cases  was  associated  with  intractable
seizures in our study. Manoj et al1 stated abnormal neuroimaging was associated
with intractable seizures in his study.
     The commonest cause of seizure in the cases was remote symptomatology in
our study. Similar results were shown by Atlunbasak et al7, Berg et al3 and Manoj et
al1 in their studies.
SUMMARY OF THE
RESULTS &
CONCLUSIONS
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SUMMARY OF THE RESULTS AND CONCLUSIONS
The following factors were found to be significantly associated with
Intractable Epilepsy in our study
? Age of onset < 1 year
? Status epilepticus
? Neonatal seizures
?  Myoclonic seizures
? Birth asphyxia
? Developmental delay
? Abnormal neurological examination
? Microcephaly
? Language delay
? Quadriplegia
? Abnormal EEG
? Abnormal MRI scan
? Remote symptomatic etiology
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            Children presenting with Myoclonic seizures, Age of onset <1year, Status
epilepticus, Neonatal seizures,  Birth asphyxia, Developmental delay, Microcephaly,
Abnormal findings on EEG and MRI must be identified early and referred to a
specialist for optimization of pharmacotherapy, considering early surgery in
selective cases and trial of the newer modalities of treatment. Early identification is
also important for parental counseling regarding the nature of the disease and
importance of compliance to medications.
      In  our  study  the  commonest  cause  of  Intractable  Epilepsy  was  perinatal
asphyxia. Perinatal asphyxia can be prevented by good nutrition during pregnancy,
regular antenatal checkups with detection of high risk pregnancy, promoting hospital
deliveries and prompt resuscitation of newborn when required.
Status epilepticus is also a significant risk factor for Intractable Epilepsy.
It must be prevented by counseling mothers regarding compliance to drugs and to
seek medical facilities for early intervention when seizures occur.
RECOMMENDATIONS
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RECOMMENDATIONS
           It would be of great interest to study the etiology of Intractable Epilepsy
using newer modalities of investigations like (PET) Positron Emission
Tomography, (SPECT) Single Photon Emission Computed Tomography, (f MRI)
Functional Magnetic resonance Tomography. These modalities of investigations
help in accurate identification of the Epileptogenic zones which gives clue to the
etiology and also aids in surgical intervention. This will help in, more effective
management and better outcome of children with intractable seizures.
BIBLIOGRAPHY
BIBLIOGRAPHY
1.   Manoj  Gulabrao  Patil,  Sushma  Malik,  Surekha  Joshi,  Mano  Gajre.  Early
Predictors of Intractable Childhood Epilepsy, Bombay Hospital Journal,
Vol.51, Nov 1, 2009.
2.  Sanjay Chawla MD, Satinder Aneja MD, Ravi Kashyap MD, Venkatesan
Mallika MD. Etiology and clinical Predictors of Intractable Epilepsy. Pediatric
Neurology, Vol.27, Issue 3, Sept 2002, Pg 186-191
3.  Anne T Berg, Susan R Levy, Edward J Novotny, Schlomo Schinnar.
Predictors of Intractable Epilepsy in childhood: A case control study,
Epilepsia Vol 37, Issue 1,pg 24-30, Jan 1996.
4.  Javad Akhondian MD, Farhad Hyderian MD, Syed Ali Jafari MD, Predictive
Factors of Paediatric Intractable Seizures ,Archives of Iranian medicine,
Vol 9, no:3 ,2006 , Pg 236-239.
5.  Dr Peter R. Hutlenlocher MD, Ronald J Hapke BA. A follow up study of
intractable seizures in childhood Annals of Neurology, Vol .28, Issue 5,
Pg 699 -705, Nov 1990.
6.  Dr. Corol Camfield, Dr Peter Camfield MD, Bruce Smith PhD, Joseph.
Outcome of childhood epilepsy: A population based study with a simple
predictive scoring system for those treated with medication. The journal of
Paediatrics, Vol 122, Issue 6, June 1993, Pg 861-868
7.  Sakir Atlunbasak MD, Faruk Incecik MD, Ozlem Herguiner MD, H.Refik
Burgut PhD .Prognosis of patients with seizures occurring in first 2 years,
Journal of child neurology 2007,  Vol 22 , Pg 195-199
8.  Singhvi JP, Sawhney IM, Lal V , Pathak A ,Prabhakar S Neurology India Year
2000 , Vol 48 ,Issue 4 ,Pg 351-356.
9.  Malik MA, Hamid MH, Ahmed TM, Ali Q Predictors of intractable childhood
epilepsy. J.Coll. of Physicians Surg. Pale. 2008 Mar 18(3) 158-162.
10.   Aithala  Gururaj,  Laszlo  Sztriha,  Joseph  Hertecant,  Valsamma  Eapen  clinical
predictors of intractable childhood epilepsy. Journal of Pshycosomatic
Research Vol 61, Issue 3, Sep 2006, Pg 343-347.
11.  Udani VP, Dharnidharka V, Nair A, Oka M, Difficult to control epilepsy in
childhood. A long term study of 123 cases, Pediatrics 1993; 30, 1199-1206.
12.  Livingston JH .management of intractable epilepsy Arch Dis Child 1991; 66,
1454-56
13.  Ohtsuka Y, Yoshinaga H, Kobayashi K. Symposium Refractory childhood
epilepsy & factors related to refractoriness, Epilepsia 2000 41:14-7
14.  Errikson KJ, Koivikko MJ. Prevalence, classification & severity of epilepsy
and epileptic syndromes in children Epilepsia 1997; 38 1275-82
15.  Bourgeois BF, Prensky AL, Palkes HS, Talent BK, Busch SG. Intelligence in
epilepsy- A Prospective study in children Ann .Neurology 1983; 438-444.
16.  Duncan JS, Sander JW, Sisodiya SM, Walker MC – Adult epilepsy. Lancet
2006:1087-100.
17.  Kleigman, Behrman, Jenson, Stanton .Nelson Textbook of Paediatrics: Vol 2:
Pg 2457-2463
18. Matti Sillanpaa ,Meria Jalava ,Olli Kaleva ,Shlomo Shinnar, The new England
journal of medicine 1998 ;338:1715-1722.
19.  Willem F.M Arts, Ada T Geerts, Oebele F Brouwer ,A.C Boudewyn Peters
,Hans Stroinke and Cees A van Donselaar .
20.  Noshed L Shorwon SD, Mortality in Epilepsy Epilepsia 1997; 38:1059-61.
21.  Aicardis Epilepsy in Children, Alexis Arzimanoglou, Renzo Gurrini, Jean
Aicardi.
22.  Jacqueline A .French MD. Refractory Epilepsy one size cannot fit all.
Epilepsy current 2006, Nov: 6(6)177-180
23.  Patrick Kwan, Alexis Arzimanoglou, Anne T Berg , Martin J Brodie, Allen
Hauser Gary Maltern, Solomon L Moshe, Emilio Perrecca ,Samuel Wiebe
Jacqueline. French Definition of Drug Resistant Epilepsy-Epilepsia 2010
,51(6)1069-1077.
24.  Nihuni N, Nishiyama K  Balb TL , Ying Z ,Najm I, Obomoto T – Decreased
Calmodulin-NR,CO assembly as a mechanism for focal epilepsy in cortical
dysplasia Neuro report 1999;10:1609-12.
25.   Aicardi  J,  Shorvon  S  Intractable  Epilepsy:  Engel  V  Pedley  Epilepsy  a
comprehensive textbook 1st edtion 1998; 1325-1331.
26.  Berg AT, Shinnar S, Levy SR, Testa FM –Smith  Rapport S, Beckerman  B -
Early development of intractable epilepsy in children :a prospective study.
Neurology 2001; 56:1445-52.
27.  Perucca E-Pharmaco resistance in Epilepsy: How should it be defined? CNS
Drugs 1998; 10:171-9.
28.  Kwan P, Brodie MJ –Early identification of Refractory epilepsy N.Engel J
Med 2000:342:314-9.
29.   Sangeeta  H  Ravert,  Vivek  Jain.  Refractory  Epilepsy  Journal  of  the  Indian
medical Association Vol 108 No: 07 Pg 418-430.
30.  David R Chabolla MD Medically Refractive Seizures. Jacksonville Medicine
Aug 2000; 12:45-56.
31.  Jerome Engel JR, Timothy A Pedley. Epilepsy a comprehensive textbook
pg 1366-1367.
32.  Neil McIntosh, Peter Helms, Rosalind Smyth, Stuart Logan. Farfar and Arneil
Textbook of Pediatrics, 7th edition,  Pg 852-868.
33.  Kenneth Swaiman, Stephen Ashwal, Donna M Ferriero. Pediatric Neurology
Principles and Practice 4th edition, Pg 986-987, pg 1151-1164.
34.  John N Mekes, Harvey B Saranat, Barnard L Maria. Child neurology,
9th edition Pg- 908
ANNEXURES
PROFORMA
NAME                                                 AGE               SEX                  Dc.No:
WEIGHT                                                                          HOSPITAL NUMBER
ADDRESS                                                                        CONTACT NUMBER
COMPLAINTS
PRESENT HISTORY
01. Type of seizures
A Generalised tonic clonic
B Tonic
C  Clonic
D Myoclonic
E Atonic
F Absence
G Simple partial
H Complex partial
I Partial seizures with secondary
generalization
02. Frequency
a.1/year b. 1/month c.>1/month d. 1/week e. >1/week f. >1/day
03. NO of AED tried so far
  a. Phenytoin
  b. Phenobarbitone
  c. Carbemezipine
  d. Sodium Valproate
  e. Lamotrigine
  f. Topiramate
  g. Levitirecetam
04. Duration of AED tried so far
No of drugs used a.>18 months b.   >2 years >   3 years
1.  >2
2. >3
05. Maximum dose used
a. >2 drugs b. >3 drugs c. > 4 drugs
06. Duration of seizure
a.< 20 minutes c. > 20 minutes
07. ETIOLOGY AND PREDICTORS OF INTRACTABLE SEIZURES
A. Age at onset of first seizures
1.        <1 year 2.         1- 5 years 3.        > 5 years
 B. Sex
          1. Male          2. Female
  C. Seizure frequency
1. >1/ Day 2. >1/Week 3. >1/Month 4. >1/ 6 Months 5. > 1/ Year
D Type of seizures
E Febrile seizures Present Absent
F Family History of Seizures Present Absent
G Birth Asphyxia Present Absent
H Developmental Delay Present Absent
I Neonatal seizures Present Absent
J CNS Infections Present Absent
K Stroke Present Absent
L H/O Head trauma Present Absent
M Abnormal Neurological Examination Present Absent
N Abnormal EEG Present Absent
O Lesion on CT Present Absent
P Lesion on MRI Present Absent
EXAMINATION
General examination
EXAMINATION OF THE CNS
     HIGHER FUNCTIONS:
     CRANIAL NERVES:
     MOTOR SYSTEM:
1. Bulk
2. Tone
3. Power
4. Reflexes
Superficial Reflexes
  Babinski’s
 Deep Reflexes
 Jaw jerk
Biceps
 Triceps
Knee
Ankle
SENSORY SYSTEM:
CEREBELLAR SIGNS:
EXAMINATION OF SKULL AND SPINE
EXAMINATION OF OTHER SYSTEMS
CVS
RS
ABDOMEN
INVESTIGATIONS
Hb
TC
DC
PLATELET
URINE FOR METABOLIC SCREENING
LFT
RFT
EEG
CT
MRI
OPHTHAL EVALUATION
ENT  EVALUATION



MASTER CHART - CASES
NAME AGE SEX Sez. fre Typ.of sz No AED Onst<1yr Fa h/o sz Feb.  sz Sta. Epi Neo.sz CNS infe BA DD Neu. cut Microcep Neu. Exa EEG CT MRI
Gokulakrishnan 2  1 3 1 3 1 2 2 1 2 2 1  1 2 1 1 1 1 1
Mubeena 3  2 3 1 3 2 2 2 1 2 2 1  1 2 1 1 1 1 1
Thamizhselvan 3  1 1 2 3 1 2 2 2 1 2 1  1 2 1 1 1 1 1
Gouse Basha 3  1 3 2 3 2 2 1 2 2 2 2  2 2 2 2 1 1 1
Aravind 3  1 3 2 4 2 1 1 2 2 2 2  2 2 2 2 1 2 2
Pavithra 3  2 1 1 3 1 2 2 2 2 2 2  2 1 2 2 1 1 3
Karthikeyan 3  1 3 1 3 2 1 2 1 2 2 1  1 2 1 1 1 1 3
Vijay 3  1 3 1 3 1 1 1 2 1 2 1  1 2 2 1 1 1 3
Archana 3  2 1 1 3 1 2 2 1 2 2 2  1 2 2 1 1 1 3
Mahesh 3  1 3 2 3 2 2 2 1 2 2 2  2 2 2 2 1 2 1
Desarani 3  2 3 1 3 1 2 2 1 2 2 1  1 2 1 2 1 1 1
Vetrivel 2  1 3 1 3 1 2 1 2 2 2 1  1 2 1 1 1 2 1
Samuel 2  1 3 2 3 1 2 2 2 2 2 2  2 2 2 2 1 2 2
Gopinath 2  1 1 1 3 1 2 2 2 1 2 1  1 2 1 2 1 2 2
Arunraj 2  1 3 1 3 2 2 2 2 2 2 1  2 2 1 2 2 1 3
Manimegalai 3  2 1 1 4 1 2 2 2 2 1 2  2 2 1 1 1 1 3
Srikanth 3  1 3 1 3 2 2 1 2 2 2 2  2 2 2 2 1 1 1
Seeniammal 3  2 3 2 3 2 2 1 2 2 2 2  2 2 2 2 1 2 2
Vignesh 3  1 1 1 3 1 2 2 2 1 2 2  2 1 1 2 1 1 1
Imtiyaz 3  1 2 1 4 1 2 2 2 2 2 2  1 2 2 1 1 1 1
Yuvaraj 2  1 1 1 3 1 2 2 2 2 2 2  2 2 1 1 1 1 1
Durgasree 3  2 1 1 3 1 2 2 2 2 2 2  2 1 1 2 1 1 1
NAME AGE SEX Sez. fre Typ.of sz No AED Onst<1yr Fa h/o sz Feb.  sz Sta. Epi Neo.sz CNS infe BA DD Neu. cut Microcep Neu. Exa EEG CT MRI
Kamaraj 2  1 1 1 5 3 2 1 1 2 2 1  1 2 1 1 2 1 1
Mohanaraja 2  1 1 1 3 1 2 1 2 2 2 1  2 2 1 1 2 2 2
Balamurugan 1  1 1 2 3 1 2 2 1 2 2 1  1 2 2 1 1 2 1
Senthil 1  1 2 1 4 2 2 1 2 2 2 2  2 2 2 2 1 2 1
Suhasini 3  2 1 1 5 2 2 1 2 2 2 2  2 2 2 1 1 2 1
Vasantha 1  1 3 2 3 3 2 2 1 2 2 2  1 2 1 1 2 2 1
Sheela 2  2 1 2 3 2 2 2 2 2 2 2  2 2 1 1 1 2 1
Siva Kumar 3  1 2 1 3 1 1 2 1 1 2 2  2 1 2 2 1 1 1
Suresh 1  1 1 1 3 1 1 2 1 1 2 2  2 2 2 1 1 2 1
Gayathri 2  2 1 1 3 2 2 1 2 2 2 1  1 2 2 1 1 2 2
Mohammad 1  1 1 1 5 2 2 1 1 2 2 1  1 2 2 1 1 2 2
Angelin 3  2 1 1 3 1 2 1 1 2 2 1  1 2 1 1 1 2 2
Prakatheeswaran 1  1 2 1 3 1 2 1 2 2 2 1  2 2 1 2 1 1 2
Kathiravan 3  1 1 2 3 1 2 2 1 1 2 1  1 2 1 1 1 1 1
Sudakar 2  1 3 1 4 1 2 2 1 2 2 1  1 2 1 1 1 2 3
Mageshwari 3  2 1 1 3 1 1 2 2 2 2 2  1 2 2 2 2 2 2
Raghunathan 3  1 1 1 3 2 2 2 1 1 2 2  1 2 2 1 1 1 1
Arunachalam 3  1 2 2 3 1 2 2 1 2 2 2  2 2 2 1 1 1 1
Sridevi 2  2 3 2 3 1 1 2 1 2 2 1  1 2 1 2 2 2 2
Janagan 3  1 1 1 4 1 2 2 1 2 2 1  1 2 1 1 1 2 1
Rajasekaran 2  1 3 1 3 1 2 1 1 1 1 2  2 2 2 1 1 2 1
Balakrishnan 3  1 2 1 3 1 1 2 2 2 2 2  1 2 2 2 2 1 3
Ganesh 2  1 1 1 5 2 2 2 1 2 2 1  2 2 1 1 1 1 2
Kamalakannan 3  1 3 1 3 1 2 2 1 2 2 2  1 2 2 1 1 2 1
NAME AGE SEX Sez. fre Typ.of sz No AED Onst<1yr Fa h/o sz Feb.  sz Sta. Epi Neo.sz CNS infe BA DD Neu. cut Microcep Neu. Exa EEG CT MRI
Uma Devi 1  2 2 1 3 2 2 2 2 2 2 1  2 2 2 1 2 2 2
Rajesh 1  1 1 1 3 1 2 2 1 2 2 2  2 2 2 1 2 2 1
Sakthivel 3  1 1 2 4 1 2 1 1 1 2 2  1 2 2 1 1 2 1
Gomathi 2  2 1 1 3 2 2 2 2 2 2 1  1 2 1 1 1 1 2
Raghavan 3  1 1 1 3 1 2 2 2 2 2 2  2 2 2 1 2 2 2
Manohar 2  1 2 1 3 3 2 1 1 2 2 1  1 2 2 2 1 2 1
Lakshmi 2  2 1 2 3 1 2 1 1 2 2 2  1 2 2 1 1 2 1
Basakaran 3  1 3 1 3 1 2 2 2 1 2 2  1 2 2 1 1 1 3
Palanivel 1  1 2 1 3 2 2 2 1 2 2 1  1 2 1 2 1 2 2
Ezhumalai 3  1 1 1 3 2 2 1 1 2 2 2  2 2 2 1 1 2 1
Chandrasekar 2  1 2 1 3 1 2 2 1 2 2 2  2 2 2 1 1 2 1
Ashwini 2  2 1 1 3 1 2 2 2 2 2 1  2 2 2 2 1 1 2
Sadagopan 3  1 1 1 3 2 2 2 2 1 2 2  1 2 2 1 1 2 1
Santhanam 2  1 2 2 3 1 2 1 1 2 2 1  1 2 2 1 1 2 2
Geetha 3  2 1 1 3 1 2 2 1 2 2 2  1 2 2 2 1 1 1
Gnanavel 3  1 2 1 3 3 2 2 2 1 2 1  1 2 2 1 1 2 1
Subramanian 3  1 1 1 3 1 2 2 1 2 2 1  2 2 2 1 1 2 2
MASTER SHEET  -  CONTROLS
NAME AGE SEX
Sez.
fre
Typ.of
sz
No.
AED
Onst.
<1yr
Fa.
h/o sz
Feb.
sz
Sta.
Epi
Neo.
sz
CNS
infe
BA DD
Neu.
cut
Microcep
Neu.
Exa
Abn
EEG
Abn
CT
Abn
MRI
Mathiazhagan 1 1 5 1 1 1 1 1 1 2 2 1  1 2 2 1 1 1 3
Thenmozhi 3 2 4 1 2 2 2 2 2 2 2 2  2 2 2 2 1 2 2
Vajiravelu 2 1 5 1 1 2 1 2 2 2 2 2  2 2 2 1 2 2 2
Suramanjiri 2 2 5 2 1 2 2 2 1 2 2 2  2 2 2 2 2 2 3
Perumal 2 1 5 2 2 1 2 1 2 2 2 2  2 1 2 2 1 1 3
Kirubakaran 3 1 5 1 2 2 2 2 2 1 2 1  1 2 1 1 2 1 3
Porkodi 3 2 5 2 1 2 2 2 2 2 2 2  2 2 2 2 2 2 2
Vinayagam 2 1 4 1 1 1 2 2 1 2 2 2  2 2 2 2 2 2 2
Boopalan 1 1 4 2 1 3 1 1 2 2 2 2  2 2 2 2 2 2 2
Malarvizhi 2 2 5 1 3 2 2 2 2 2 2 2  2 2 2 2 1 1 3
Krishmoorthy 2 1 5 1 1 2 2 2 2 2 2 2  2 2 2 2 1 2 2
Gopal 2 1 5 2 2 1 2 1 1 2 2 1  2 1 1 1 1 1 3
Ilavarasi 3 2 5 1 1 2 1 2 2 2 2 2  2 2 2 2 2 2 2
Vishwanathan 2 1 4 1 2 3 2 2 2 2 2 2  2 2 2 1 2 2 1
Rajkumar 1 1 5 1 1 2 2 2 2 2 2 2  2 2 2 2 1 1 3
Kalaiselvi 2 2 5 2 1 1 2 1 1 2 2 2  2 2 2 2 2 2 1
Soundarajan 3 1 4 1 3 2 1 2 2 2 2 2  2 2 2 2 2 2 2
NAME AGE SEX
Sez.
fre
Typ.of
sz
No.
AED
Onst.
<1yr
Fa.
h/o sz
Feb.
sz
Sta.
Epi
Neo.
sz
CNS
infe
BA DD
Neu.
cut
Microcep
Neu.
Exa
Abn
EEG
Abn
CT
Abn
MRI
Thandapani 2 1 5 2 1 2 2 2 2 2 2 2  2 2 2 1 1 1 3
Naveen Kumar 2 1 4 1 1 2 2 2 2 1 2 1  1 2 2 1 1 1 2
Junaitha Banu 2 2 5 1 2 3 2 1 2 2 2 2  2 2 2 2 1 2 2
Thiyagaraj 3 1 4 1 1 2 1 2 2 1 2 2  2 2 2 2 2 2 2
Rathinavel 3 1 5 1 1 1 2 2 2 2 2 2  2 1 2 2 2 1 3
Iyngaran 3 1 5 2 2 2 2 2 2 2 2 2  2 2 2 2 2 2 2
Vijayalaksmi 3 2 5 1 1 2 2 2 1 2 2 2  2 2 2 2 1 2 2
Humayoon 2 1 4 1 1 3 1 1 2 2 2 2  2 2 2 2 2 1 3
Marunraj 2 1 4 1 1 3 2 2 2 2 2 2  2 2 2 2 1 2 2
Dhanavanthini 3 2 5 1 2 1 2 2 2 2 2 2  2 2 2 2 2 2 1
Venkatesh 3 1 5 2 1 3 2 2 2 2 2 2  2 2 2 2 1 1 3
Madhumitha 2 2 4 1 1 3 2 2 1 2 2 1  1 2 2 1 1 1 3
Ravichandran 3 1 5 1 1 2 2 1 2 2 2 2  2 2 2 2 2 2 1
Jayaganapathy 3 1 5 1 2 1 1 2 2 2 2 2  2 2 2 2 1 2 2
Manjunath 3 1 5 1 1 1 1 1 2 2 2 2  2 2 2 2 2 2 1
Arun Kumar 3 1 5 1 1 2 2 2 1 1 2 1  2 2 2 2 1 1 2
Parvathy 2 2 5 1 3 2 2 2 2 2 2 2  2 2 2 2 2 2 1
Assif Baig 3 1 4 2 1 2 2 2 2 2 2 2  2 2 2 2 1 2 2
Suryaprakash 2 1 5 1 1 1 1 1 2 2 2 2  2 2 2 2 2 1 3
NAME AGE SEX
Sez.
fre
Typ.of
sz
No.
AED
Onst.
<1yr
Fa.
h/o sz
Feb.
sz
Sta.
Epi
Neo.
sz
CNS
infe
BA DD
Neu.
cut
Microcep
Neu.
Exa
Abn
EEG
Abn
CT
Abn
MRI
Jayakumar 2 1 5 1 1 2 2 2 2 2 2 2  2 2 2 2 2 2 1
Archana 3 2 5 1 2 2 2 2 2 2 2 1  1 2 1 1 1 2 3
Ramesh 2 1 5 1 1 3 2 2 1 2 2 2  2 2 2 2 2 2 2
Narayanamoorthy 1 1 5 2 1 2 2 1 2 2 2 2  2 2 2 2 1 2 1
Poornima 2 2 4 1 1 2 2 2 2 2 2 2  2 2 2 2 2 1 3
Lokeshwaran 2 1 5 1 2 1 2 2 2 2 2 2  2 2 2 2 1 2 2
Selvaraj 3 1 5 1 1 3 1 2 2 2 2 2  2 2 2 2 2 2 2
Prabhu Shankar 2 1 4 2 1 2 2 1 1 2 2 2  2 2 2 2 2 2 1
Kalaimathi 3 2 4 1 1 3 2 2 2 2 2 2  2 2 2 2 2 1 3
Sunil Joshua 2 1 5 2 2 2 2 2 2 2 2 2  2 2 2 2 1 2 2
Sabarinathan 2 1 5 1 2 2 1 2 2 2 2 2  2 2 2 2 2 2 2
Anand 3 1 4 2 1 3 2 2 2 2 2 2  2 2 2 2 1 2 2
Meenakshi 2 2 4 1 2 1 2 1 2 2 2 2  2 2 2 2 2 2 1
Akshatha 2 2 5 2 1 3 2 2 2 2 2 2  2 2 2 2 2 1 3
Dillibabu 3 1 5 1 2 2 1 2 1 2 2 2  2 2 2 2 1 2 2
Dharani 3 2 4 2 1 3 2 2 2 2 2 2  2 2 2 2 2 2 2
Narmatha 2 2 5 1 2 2 2 2 2 1 2 1  1 2 1 2 1 1 3
Rajarajeshwari 1 2 5 1 2 1 2 2 2 2 2 2  2 2 2 2 1 2 1
Sasikumar 2 1 5 1 1 2 2 2 2 2 2 2  2 2 2 2 2 2 2
NAME AGE SEX
Sez.
fre
Typ.of
sz
No.
AED
Onst.
<1yr
Fa.
h/o sz
Feb.
sz
Sta.
Epi
Neo.
sz
CNS
infe
BA DD
Neu.
cut
Microcep
Neu.
Exa
Abn
EEG
Abn
CT
Abn
MRI
Dheena 2 1 4 1 2 3 2 1 2 2 2 2  2 2 2 2 2 2 2
Suganya 2 2 5 2 1 2 1 2 2 2 2 2  2 2 2 2 1 2 2
Varadarajan 3 1 5 1 2 3 2 2 2 2 2 2  2 2 2 2 2 2 1
Deepika 3 2 4 1 1 3 2 2 1 2 2 2  2 2 2 2 2 2 2
Nandagopal 3 1 5 2 2 1 2 1 2 2 2 1  2 2 2 2 1 1 3
Sangeetha 2 2 5 1 1 2 2 2 2 2 2 2  2 2 2 2 1 2 2
Pandiyan 2 1 5 1 1 2 1 2 2 2 2 2  2 2 2 2 1 1 3
Janani 2 2 5 1 1 2 2 1 2 2 2 2  2 2 2 2 1 1 3
KEY TO MASTER CHART
Age
1 -     1-2 years
          2    -     2-5 years
          3    -     5-12 years
Sex
          1 -Male
          2 - Female
Seiz.fre. – SEIZURE FREQUENCY
          1 - Daily seizures
          2 - > 1/week
          3 - > 1 /month
          4 - > 1/ 6 months
          5 - > 1/year
Typ. of sz – TYPE OF SEIZURES
          1 – Generalised
          2 - Partial
No. AED – NUMBER OF AED
          1 - One AED
          2 - Two AED
          3 - Three AED
          4 - Four AED
          5 - Five AED
Onst. < 1 yr – ONSET < 1 YEAR
          1 - < 1 year
          2 - > 1 year
Fa h/o sz – FAMILY HISTORY OF SEIZURES
          1 - Present
          2 - Absent
Feb. sz – FEBRILE SEIZURES
          1 - Present
          2 - Absent
Sta. Epi – STATUS EPILEPTICUS
          1 - Present
          2 - Absent
Neo. sz – NEONATAL SEIZURES
         1 - Present
         2 - Absent
CNS infec – CNS INFECTION
        1 - Present
        2 - Absent
BA – BIRTH ASPHYXIA
        1 - Present
        2 - Absent
DD – DEVELOPMENTAL DELAY
        1 - Present
        2 - Absent
Neu.cut – NEUROCUTANEUS MARKERS
        1 - Present
        2 - Absent
Microcep. – MICROCEPHALY
       1 -Present
       2 - Absent
Neu. Exa – NEUROLOGICAL EXAMINATION
       1 - Abnormal
       2 - Normal
EEG – ELECTRO ENCEPHALOGRAPHY
        1 - Abnormal
        2 - Normal
CT – COMPUTED TOMOGRAPHY OF BRAIN
        1 - Abnormal
        2 - Normal
MRI – MAGNETIC RESONANCE IMAGING OF BRAIN
        1 - Abnormal
        2 - Normal
        3 - Not taken
ABBREVIATIONS USED IN THE BOOK
AED - Anti Epileptic Drugs
EEG -  Electro Encephalography
MRI - Magnetic  Resonance  Imaging
CT - Computed Tomography
No -  Number
